Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 9 September 2021

 
 
 
   

19 Conversations | EFPIA's Podcast Series
 
Listen to the podcast
Today we're asking Luc Van Steenwinkel, Site Lead, Pfizer Puurs and Vice President Pfizer Biotech Operations, and Danny Hendrikse, Vice President, Pfizer Global Supply Chain,

"From raw materials to patients’ arms – how are COVID-19 vaccines made?"

Listen to hear their discussion on the challenge and how we're preparing for the future.


Read more


 
 
 
   

News
 

Improving Central and Eastern Europe health systems’ resilience and outcomes through higher...
02 September 2021

A new report highlights the need for increased healthcare spending in CEE countries and explores ways to increase efficiency... Read more
 
 
 
   

Catch up with EFPIA's recent events
 
How can COVID-19 treatments help us on the road to recovery?
While vaccination programmes continue to scale up around the world, therapeutics play a key role in saving lives, freeing... Read more
AMR: how can we prevent the next pandemic?
While the COVID-19 pandemic caught the world by surprise, AMR is a predictable and preventable crisis and we have a... Read more
 
 
 
   

Upcoming events
 

Building an Attractive Environment for Clinical Research in Turkey
14 September 2021 (Virtual event)

Jointly organised by AIFD and EFPIA. Read more

INNODIA & INNODIA HARVEST webinar
23 September 2021 (Virtual event)

Arresting type 1 diabetes in Europe Read more

Health Systems after COVID-19 - how can the industry contribute to strengthened resilience?...
24 September 2021 (Virtual event)

In the effort to making health systems more resilient to future pandemics and other shocks, both public institutions... Read more

Launch of the European Alliance for Cardiovascular Health
27 September 2021 (Virtual event)

Save the Date Read more

How can we close the East-West healthcare investment gap in Europe?
04 October 2021 (Virtual event)

Public healthcare spending in CEE countries has grown over time, but at a slower pace than GDP growth and today the... Read more

Accelerating Global Deletion of the Abnormal Toxicity Test. Planning common next steps.
14 October 2021 (Virtual event)

Organised by AFSA/HSI and EFPIA in collaboration with IABS, the workshop aimed to assess the lingering barriers, to... Read more
 
 
 
   

What we published
 

Healthcare outcomes and expenditure in Central and Eastern Europe – a review
02 September 2021 (Publications)

Improving Central and Eastern Europe health systems’ resilience and outcomes through higher and more efficient healthcare... Read more

Addressing unmet needs in extremely rare and paediatric-onset diseases: how the biopharmaceutical...
28 July 2021 (Publications)

A report by Dolon Read more

Health systems after COVID-19
15 July 2021 (Publications)

A perspective on the future of European health systems Read more
 
 
 
   

What we are reading
 
EURORDIS Black Pearl Awards 2022
On 09 September 2021 (EURORDIS)

Nominations deadline: 10th September 2021. Read more
Health systems after COVID-19 – Building resilience through a value-based approach
On 18 August 2021 (European Alliance for Value in Health)

Health system resilience has been rising in the political agenda throughout the last decade, becoming a key political... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2024 All rights reserved Disclaimer